Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04235660 · ClinicalTrials.gov registry record · NA
Y90 Radiation Segmentectomy vs SBRT for HCC
A NA study, sponsored by Indiana University.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT04235660 is a NA study that was terminated before completion, run by Indiana University. The registered enrollment target is 2 participants.
The verdict
NCT04235660, a NA study, was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The proposed study is a single site, prospective, randomized pilot study to assess the feasibility of recruitment of patients into a trial evaluating the efficacy and tolerability of selective transarterial Y90 radioembolization (radiation segmentectomy) versus stereotactic body radiation therapy (SBRT) for solitary early stage (≤ 3cm) hepatocellular carcinoma (HCC).
Interventions
- RADIATION Stereotactic Body Radiation Therapy
- RADIATION Yttrium-90 Radiation Segmentectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2020-07-22 |
| Est. Completion | 2022-03-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04235660
The ClinicalTrials.gov registry entry for NCT04235660 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Stereotactic Body Radiation Therapy is the first listed.
NCT04235660 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04235660 about?
NCT04235660 is a clinical study titled "Y90 Radiation Segmentectomy vs SBRT for HCC". The proposed study is a single site, prospective, randomized pilot study to assess the feasibility of recruitment of patients into a trial evaluating the efficacy and tolerability of selective transarterial Y90 radioembolization (radiation segmentectomy) versus stereotactic body radiation therapy (S...
What is the current status of trial NCT04235660?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2020-07-22. Estimated completion is 2022-03-08.
What interventions are being tested in trial NCT04235660?
The interventions under investigation include: Stereotactic Body Radiation Therapy (RADIATION), Yttrium-90 Radiation Segmentectomy (RADIATION).
Who is sponsoring clinical trial NCT04235660?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.